income_security_and_social_services · health · food_and_nutrition · education · HHS-NIH11

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

National Institutes of Health · RFA-NS-25-023

157 days left

Award Range

$0 – $350K

Deadline

January 15, 2027

GRANTQUICK SUMMARYPlain-English Overview

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed). National Institutes of Health. This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to... up to $350,000 per award.

Who Should Apply

City/township governments, For-profit organizations, Public And Indian Housing Authorities, Public universities/colleges, Independent school districts (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

•Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
•Deadline: 2027-01-15

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).

Attachments

PDF

RFA-NS-25-023 Full Announcement Text

RFA-NS-25-023-Full-Announcement.html

Who Can Apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Eligible Applicant Types

City/Township GovernmentsFor-Profit OrganizationsPublic And Indian Housing AuthoritiesPublic Colleges & UniversitiesIndependent School DistrictsSmall BusinessesState GovernmentsSpecial District GovernmentsFederally Recognized Tribal GovernmentsOther (see NOFO for details)County Governments501(c)(3) NonprofitsOther Tribal OrganizationsNonprofits without 501(c)(3)Private Colleges & Universities

Funding Details

Maximum Award: $350K
Cost Sharing Required?: No
Funding Instrument: grant

Key Dates

Posted: September 18, 2024

Application Deadline: January 15, 2027 (157 days remaining)

Agency Contact

NIH Grants Information grantsinfo@nih.gov

grantsinfo@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov